Family Medicine · Hammond, LA
NPI
1356324594
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
16052 Doctors Blvd
Hammond, LA, 70403
Phone (985) 345-9606
Groups this clinician bills Medicare through
Medicare paid, 2024
$110K
2,543 services
Medicare patients, 2024
503
Average age 74
Drug cost, 2024
$1.2M
13,636 prescriptions
Company payments, 2025
$1,544
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Claude W Gilbreath was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 888 times for 98 patients. In total Claude W Gilbreath billed 2,543 services in 48 codes, and Medicare paid $110K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-08-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 888 | 98 | $0.08 | $70.71 |
| 99213 Office E&M - Established | Office | 407 | 234 | $61.56 | $25K |
| 99214 Office E&M - Established | Office | 386 | 267 | $82.36 | $32K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 307 | 307 | $116.98 | $36K |
| 99497 Care Management/Coordination | Office | 58 | 58 | $76.58 | $4,442 |
| 81003 Clinical Chemistry | Office | 38 | 35 | $2.20 | $83.6 |
| 87804 Immunoassay | Office | 34 | 17 | $16.22 | $551 |
| 87635 COVID Specific | Office | 29 | 29 | $48.55 | $1,408 |
| 83036 Blood Count | Office | 29 | 25 | $9.52 | $276 |
| 93000 Electrocardiogram | Office | 19 | 19 | $9.41 | $179 |
| 87811 Immunoassay | Office | 18 | 17 | $40.55 | $730 |
By year: 2022 $85K for 1,739 services; 2023 $110K for 2,270 services; 2024 $110K for 2,543 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 38 | 35 | $2.20 | $83.6 |
| 87804 Immunoassay | 34 | 17 | $16.22 | $551 |
| 83036 Blood Count | 29 | 25 | $9.52 | $276 |
| 87635 COVID Specific | 29 | 29 | $48.55 | $1,408 |
| 87811 Immunoassay | 18 | 17 | $40.55 | $730 |
Medicare prescription drug claims, 2024
In 2024, the drug Claude W Gilbreath prescribed most often to Medicare patients was Atorvastatin Calcium, with 692 prescriptions and refills. In total Claude W Gilbreath wrote 13,636 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 692 | 1,844 | 199 | $5,795 |
| Levothyroxine Sodium Generic | 676 | 1,696 | 170 | $5,398 |
| Amlodipine Besylate Generic | 555 | 1,422 | 150 | $2,960 |
| Pantoprazole Sodium Generic | 451 | 1,115 | 130 | $5,563 |
| Benazepril Hcl Generic | 387 | 1,122 | 111 | $5,111 |
| Metoprolol Succinate Generic | 376 | 914 | 99 | $4,528 |
| Losartan Potassium Generic | 366 | 960 | 104 | $4,408 |
| Metformin Hcl Generic | 300 | 749 | 80 | $1,839 |
| Gabapentin Generic | 247 | 569 | 75 | $4,395 |
| Montelukast Sodium Generic | 217 | 503 | 61 | $1,694 |
| Rosuvastatin Calcium Generic | 210 | 588 | 71 | $2,913 |
| Trazodone Hcl Generic | 204 | 446 | 54 | $3,099 |
| Omeprazole Generic | 202 | 492 | 54 | $2,751 |
| Alendronate Sodium Generic | 192 | 446 | 56 | $1,433 |
| Buspirone Hcl Generic | 191 | 352 | 53 | $2,636 |
Brand drugs: 1,546 claims; generic drugs: 12,015 claims; opioid claims: 108.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Claude W Gilbreath $1,544 ($1,544 in general payments such as food, travel and fees) from 24 companies. The largest payer was GlaxoSmithKline, LLC. with $229.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 12 | $229 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $207 |
| Lilly USA, LLC LLY | 8 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 6 | $99.81 |
| Pfizer Inc. PFE | 4 | $82.6 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $81.84 |
| Novo Nordisk Inc NVO | 4 | $80.9 |
| Abbvie Inc. ABBV | 4 | $73.8 |
| Amgen Inc. AMGN | 4 | $66.93 |
| Boston Scientific Corporation BSX | 1 | $52.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.